Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
395 studies found for:    Baxter
Show Display Options
Rank Status Study
1 Completed Investigation of Performance and Compatibility of the Baxter Dialyzer Xenium XPH 210 During On-line Hemodiafiltration
Condition: End Stage Kidney Disease
Intervention: Device: Dialyzer Baxter Xenium XPH 210
2 Recruiting Safety and Efficacy Evaluation of Two Kinds of Peritoneal Dialysate
Condition: Kidney Failure,Chronic
Interventions: Drug: Huaren Peritoneal Dialysate;   Drug: Baxter Peritoneal Dialysate
3 Completed Swine Flu (Novel Influenza A H1N1) Vaccine Study
Condition: Influenza
Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
4 Completed Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.
Condition: Chronic Renal Failure
Intervention: Device: Baxter’s UltraBag®  and FMC Andy·Disc®
5 Completed Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
Condition: Hemophilia A
Intervention: Drug: Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)
6 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
7 Completed Blood Compatibility Characteristics of Baxter Xenium+, Fresenius FX and Gambro Polyflux Dialyzers
Condition: End Stage Renal Failure on Dialysis
8 Recruiting Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery
Condition: Adolescent Idiopathic Scoliosis
Intervention: Device: Gelatin matrix with human derived thrombin (Floseal, Baxter)
9 Completed
Has Results
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Interventions: Biological: Immune Globulin Intravenous (human), 10%;   Biological: 0.25% human albumin solution (Placebo)
10 Recruiting Use of Baxter Animated Retching Faces (BARF) Scale to Measure Nausea in Children Who Speak Spanish
Condition: Postoperative Nausea and Vomiting
11 Recruiting Lidocaine Versus Bupivacaine Block in Ambulatory Continuous With Elastomeric Pump
Condition: Hallux Valgus
Interventions: Drug: Active Comparator:   Lidocaine;   Drug: Placebo Comparator:   Bupivacaine;   Device: Baxter Infusor elastomeric pump
12 Recruiting Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures
Condition: Hemophilia A
Intervention: Biological: PEGylated Recombinant factor VIII (rFVIII)
13 Completed Post-Operative Quality of Life Evaluation for Different Anesthesia Techniques for Arthroscopic Shoulder Surgery
Condition: Rotator Cuff Injury
Interventions: Device: Baxter INFUSOR System;   Drug: Single Injection of Local Anesthetic
14 Completed FSME IMMUN NEW Follow-Up to Study 205 in Children Aged 6 to 16 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
15 Completed FSME IMMUN NEW Follow-Up to Study 199 in Children Aged 1 to 6 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
16 Recruiting Baxter: Actifuse SHAPE vs DBX in ACC
Conditions: Cervical Spine Degenerative Disease Nos;   Cervical Spondylosis With Myelopathy
Interventions: Device: Actifuse SHAPE;   Device: Autograft with Demineralized Bone Matrix
17 Terminated Long-Term Study of IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Intervention: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%)
18 Recruiting The Efficacy and Safety of Accufuser Omnibus® (Elastomeric Infusion Pump); Comparative Clinical Trial
Condition: Upper Gastrointestinal Cancer
Interventions: Device: The domestic PCA equipment 'Accufuser Omnibus®';   Device: Imported PCA equipment 'Infusor SV®, Baxter, USA'
19 Completed
Has Results
Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: Antihemophilic factor, recombinant, manufactured protein-free
20 Recruiting BAX 855 Pediatric Study
Condition: Hemophilia A
Interventions: Biological: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method;   Biological: PEGylated Recombinant Factor VIII

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years